Inner Balance, a women’s health startup founded by hormone specialist Dr. Sarah Daccarett, is gaining traction as a new contender in the hormone therapy space by challenging traditional, fragmented treatment models. With just two products currently on the market, the company is positioning itself at the intersection of modern hormone care, longevity, and streamlined clinical design.
Rethinking Hormone Therapy With Oestra™
Inner Balance’s flagship product, Oestra™, is drawing attention for its simplified approach to hormone replacement therapy (HRT). Unlike conventional regimens that often require a combination of pills, patches, and topical creams, Oestra™ is a single systemic vaginal hormone cream formulated with estradiol and progesterone.
The company says the product is designed to deliver full-body hormonal support in a more accessible format. According to internal data released by Inner Balance, users reported improvements across a wide range of symptoms, including heavy and painful periods (96%), vaginal dryness (97%), mood and mental health (78.7%), sleep quality (80.2%), libido (75.3%), skin and hair health (69.7%), brain fog (67.6%), and energy levels (63%).
These early results suggest Oestra™ may represent a new generation of hormone therapy aimed at addressing multiple symptoms through a single, systemic solution.
Hormone-Informed Skincare Enters the Spotlight
In addition to hormone therapy, Inner Balance has expanded into hormone-driven skincare with its BodyMatched™ Anti-Aging Face Cream + Finasteride. The prescription-based formulation combines topical finasteride—a DHT blocker—with estriol, tretinoin, and niacinamide.
The company says the multi-pathway approach is designed to address hormonally influenced skin concerns such as unwanted facial hair, enlarged pores, thinning and dry skin, texture changes, hormonal acne, and oil imbalance. The product reflects growing consumer and clinical interest in skincare solutions informed by hormonal science rather than surface-level treatments.
A Founder’s Response to Fragmented Care
Dr. Daccarett launched Inner Balance after years of observing what she describes as inconsistent and ineffective hormone care for women experiencing hormonal decline.
“Women don’t need more complexity—they need hormone care that works,” she said.
That philosophy underpins Inner Balance’s clinician-led model, which emphasizes simplification, accessibility, and science-backed formulations tailored to women’s long-term health needs.
Expansion Plans Signal Broader Ambitions
Inner Balance is expected to unveil additional products in 2026, signaling expansion beyond its initial offerings. While specific details have not been disclosed, the company has hinted at developments targeting metabolic health, longevity, and additional hormone-informed skincare categories.
About Inner Balance
Inner Balance is a women’s hormone health company focused on modernizing hormone therapy through streamlined, science-backed solutions. Its clinician-led platform aims to provide accessible, precision hormone care designed to support overall wellbeing and female longevity.
